With three biotechs down more than 30% today, people may have missed that ACHN was up on its first day of trading. However, this outcome is tainted because the IPO went off at a bargain basement price.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”